Treatment of Active Chronic Hepatitis with Cyclophosphamide

Overview

Journal Postgrad Med J

Publisher Oxford University Press

Specialty General Medicine

Date 1974 Jan 1

PMID 4464495

Authors

R Naccarato

R Farini

M Chiaramonte

U Fagiolo

G C Sturniolo

Affiliations

Soon will be listed here.

References

Coons A, Kaplan M . Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med. 1950; 91(1):1-13. PMC: 2135948. DOI: 10.1084/jem.91.1.1. View

Mackay I, WEIDEN S, Ungar B . TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINE. Lancet. 1964; 1(7339):899-902. DOI: 10.1016/s0140-6736(64)91627-7. View

Steinberg A, KALTREIDER H, Staples P, Goetzl E, Talal N, Decker J . Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med. 1971; 75(2):165-71. DOI: 10.7326/0003-4819-75-2-165. View

Popper H, Paronetto F, Schaffner F . Immune processes in the pathogenesis of liver disease. Ann N Y Acad Sci. 1965; 124(2):781-99. DOI: 10.1111/j.1749-6632.1965.tb19001.x. View

BEDARIDA G, Trinchieri G, CARBONARA A . The detection of Australia antigen and anti-Au antibodies by a rapid procedure combining electrophoresis and immunoprecipitation. Haematologica. 1969; 54(9):591-602. View

Krawitt E, Stein J, KIRKENDALL W, CLIFTON J . Mercaptopurine hepatotoxicity in a patient with chronic active hepatitis. Arch Intern Med. 1967; 120(6):729-34. View

Mackay I, WEIDEN S, HASKER J . Autoimmune hepatitis. Ann N Y Acad Sci. 1965; 124(2):767-80. DOI: 10.1111/j.1749-6632.1965.tb19000.x. View

Booth L, Aber G . Immunosuppressive therapy in adults with proliferative glomerulonephritis. Controlled trial. Lancet. 1970; 2(7681):1010-3. DOI: 10.1016/s0140-6736(70)92817-5. View

Mancini G, Carbonara A, Heremans J . Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965; 2(3):235-54. DOI: 10.1016/0019-2791(65)90004-2. View

10.

Fairley K, BARRIE J, Johnson W . Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet. 1972; 1(7750):568-9. DOI: 10.1016/s0140-6736(72)90358-3. View

11.

Shulman N, Barker L . Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science. 1969; 165(3890):304-6. DOI: 10.1126/science.165.3890.304. View

12.

Paterson P, Drobish D, Biddick A . Cyclosphosphamide inhibition of experimental allergic thyroiditis and thyroid antibody production in rats. J Immunol. 1971; 106(2):570-2. View

13.

MISTILIS S, BLACKBURN C . The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine. Australas Ann Med. 1967; 16(4):305-11. DOI: 10.1111/imj.1967.16.4.305. View

14.

Cook G, Mulligan R, Sherlock S . Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971; 40(158):159-85. DOI: 10.1093/oxfordjournals.qjmed.a067264. View

15.

Nakamura R, Weigle W . Suppression of thyroid lesions in rabbits by treatment with cyclophosphamide after the induction of thyroiditis. Clin Exp Immunol. 1970; 7(4):541-50. PMC: 1712849. View

16.

Alepa F, Zvaifler N, SLIWINSKI A . Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis. Arthritis Rheum. 1970; 13(6):754-60. DOI: 10.1002/art.1780130604. View

17.

Grushkin C, Fine R, Heuser E, Lieberman E . Cyclophosphamide therapy of idiopathic nephrosis. Calif Med. 1970; 113(6):1-5. PMC: 1501850. View

18.

PAGE A, Condie R, GOOD R . SUPPRESSION OF PLASMA CELL HEPATITIS WITH 6-MERCAPTOPURINE. Am J Med. 1964; 36:200-13. DOI: 10.1016/0002-9343(64)90083-x. View

19.

COWLING D, Mackay I, TAFT L . Lupoid hepatitis. Lancet. 1956; 271(6957):1323-6. DOI: 10.1016/s0140-6736(56)91483-0. View

20.

BROCK N, HOHORST H . [ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO]. Arzneimittelforschung. 1963; 13:1021-31. View